Tag: risperidone long-acting injectable
Prolactin Levels After Switching to Paliperidone Palmitate in Patients with Schizophrenia
by Masaru Nakamura, MD, PhD; Takahiko Nagamine, MD, PhD; Goro Sato, MD, PhD; and Kazue Besho, Phc Dr. Nakamura is with the Department of Psychiatric Internal Medicine, Kosekai-Kusatsu Hospital, Hiroshima, Japan; Dr. Nagamine is with the Department of Psychiatric Internal Medicine, Shinseikai-Ishii Memorial Hospital, Iwakuni, Japan; Dr. Sato is with the Department of Psychiatry, Kosekai-Kusatsu […]
Deltoid Injections of Risperidone Long-acting Injectable in Patients with Schizophrenia
by Jorge A. Quiroz, MD; Sarah Rusch, MSc; An Thyssen, PhD; Joseph M. Palumbo, MD; and Stuart Kushner, MD Dr. Quiroz was a Director in the Central Nervous System, Pain and Translational Medicine Therapeutic Area at Johnson & Johnson Pharmaceutical Research & Development, L.L.C., Raritan, New Jersey, U.S.A., at the time of the study and […]
Use of Risperidone Long-Acting Injectable in a Rural Border Community Clinic in Southern California
by Alvaro Camacho, MD; Bernardo Ng, MD; Barbara Galangue, MA; David Feifel, MD, PhD Drs. Camacho and Ng are with the Imperial County Behavioral Health, El Centro, California, the Sun Valley Research Center, Imperial, California, and the Department of Psychiatry. University of California, San Diego; Ms. Galangue and Dr. Feifel are with the Department of […]
